Health Condition 1: J309- Allergic rhinitis, unspecified Health Condition 2: J324- Chronic pansinusitis Health Condition 3: J310- Chronic rhinitis Health Condition 4: J399- Disease of upper respiratory tract, unspecified Health Condition 5: J308- Other allergic rhinitis Health Condition 6: J328- Other chronic sinusitis Health Condition 7: J338- Other polyp of sinus Health Condition 8: J348- Other specified disorders of noseand nasal sinuses Health Condition 9: J393- Upper respiratory tract hyper
Conditions
Interventions
Intervention1: MONTELUKAST: Tablet Montelukast 10mg one tablet Once orally at bedtime for 3 months
Control Intervention1: NOT APPLICABLE: NOT APPLICABLE
Control Intervention2: NIL INTERVENTION: NIL IN
Sponsors
Christian Medical College Vellore
Eligibility
Inclusion criteria
Inclusion criteria: ADULTS AGED MORE THAN 18 YEARS - MALE AND FEMALE PATIENTS DIAGNOSED WITH ALLERGIC FUNGAL RHINOSINUSITIS
Exclusion criteria
Exclusion criteria: CHILDREN LESS THAN 18 YEARS PREGNANT WOMEN PATIENT WITH CONTRAINDICATIONS TO MONTELUKAST PATIENT NOT GIVING CONSENT
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Subjective scores – SNOT 22, VAS 2. Objective scores - Lund Kennedy endoscopic gradingTimepoint: 3 MONTHS | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Skin Allergy Testing for fungal allergensTimepoint: 3 MONTHS | — |
Countries
India
Contacts
Public ContactDr. Rebecca Mridula Singh
Christian Medical College, Vellore
Outcome results
None listed